Stock data
PDS Biotechnology Corporation (PDSB)
PDS Biotechnology Corporation (PDSB) reported net income of -US$34.50M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$31.54M | -US$34.50M | — |
| 2024 | — | — | -US$36.32M | -US$37.61M | — |
| 2023 | — | — | -US$43.05M | -US$42.94M | — |
| 2022 | — | — | -US$41.67M | -US$40.85M | — |
| 2021 | — | — | -US$21.44M | -US$16.92M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$9.75M | — |
| 2026-03-31 | — | -US$7.35M | — |
| 2025-12-31 | — | -US$7.56M | — |
| 2025-09-30 | — | -US$9.01M | — |
| 2025-06-30 | — | -US$9.43M | — |
| 2025-03-31 | — | -US$8.49M | — |
| 2024-12-31 | — | -US$7.95M | — |
| 2024-09-30 | — | -US$10.73M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.